The US Food and Drug Administration’s new requirements for sponsors to follow Good Clinical Practices (GCPs) for ex-US device clinical trials will affect device development strategies, including where to conduct such trials. While FDA will not...
By: Kathleen Sanzo
By: Kathleen Sanzo